Acquisition of Tn6018-3' CS regions increases colistin MICs against Acinetobacter baumannii isolates harboring new variants of AbaRs
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články
PubMed
28238067
DOI
10.1007/s12223-017-0507-x
PII: 10.1007/s12223-017-0507-x
Knihovny.cz E-zdroje
- MeSH
- Acinetobacter baumannii klasifikace účinky léků genetika izolace a purifikace MeSH
- antibakteriální látky farmakologie MeSH
- bakteriální geny MeSH
- bakteriální proteiny genetika MeSH
- elektroforéza v polyakrylamidovém gelu MeSH
- genotyp MeSH
- infekce bakteriemi rodu Acinetobacter mikrobiologie MeSH
- kolistin farmakologie MeSH
- lidé MeSH
- lipopolysacharidy analýza MeSH
- mikrobiální testy citlivosti MeSH
- minisatelitní repetice MeSH
- multilokusová sekvenční typizace MeSH
- polymerázová řetězová reakce MeSH
- popálení komplikace MeSH
- transkripční faktory genetika MeSH
- transpozibilní elementy DNA * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- antibakteriální látky MeSH
- bakteriální proteiny MeSH
- kolistin MeSH
- lipopolysacharidy MeSH
- pmrA protein, Bacteria MeSH Prohlížeč
- PmrB protein, bacteria MeSH Prohlížeč
- transkripční faktory MeSH
- transpozibilní elementy DNA * MeSH
Colistin is the last hope to treat extensively drug resistance (XDR) Acinetobacter baumannii (A. baumannii) infections, but resistance to colistin is currently reported in clinical centers all over the world. Here, we studied two colistin-resistant A. baumannii isolates with a difference in minimum inhibitory concentrations (MICs) that were isolated from a single burn patient during treatment in the hospitalization period. The international clonal (IC) lineage, multilocus sequence typing (MLST), and multiple loci variable number tandem repeat (VNTR) analysis (MLVA) typing were used to characterize the relatedness of A. baumannii isolates. Lipopolysaccharides (LPS) and PmrAB system analysis by PCR sequencing, polyacrylamide gel electrophoresis (PAGE), and real-time PCR were performed to determine the intactness and probable modifications of the LPS as the main resistance mechanisms to colistin. A combination of PCR, sequencing, and restriction fragment length polymorphism (RFLP) was used for A. baumannii resistance islands (AbaR) mapping as resistance-determinant reservoirs. Two isolates were identical at all MLST and VNTR marker loci that indicated the isolates were the same strain. In comparison to colistin-heteroresistant A. baumannii strain TEH267 (MIC = 1.5 mg/L), colistin-resistant A. baumannii strain TEH273 (MIC ≥256 mg/L) acquired two genomic regions including Tn6018-topA sequence and topA sequence-3' CS in its AbaR structure containing ispA and cadA genes which, it would appear, could be associated with eightfold increase in colistin MIC. Both isolates had new variants of AbaR-like structures which could be derivatives of the typical AbaR3. According to the results of this study, AbaRs could be associated with an increase in MIC to colistin.
Laser Research Center Dentistry Research Institute Tehran University of Medical Sciences Tehran Iran
Zobrazit více v PubMed
J Bacteriol. 2015 Jun 15;197(12):2027-35 PubMed
Antimicrob Agents Chemother. 2006 Sep;50(9):2946-50 PubMed
Mol Microbiol. 1996 Feb;19(3):599-609 PubMed
Curr Med Res Opin. 2015 Apr;31(4):707-21 PubMed
Drug Resist Updat. 2012 Aug;15(4):237-47 PubMed
IUBMB Life. 2011 Dec;63(12):1061-7 PubMed
FEMS Microbiol Rev. 2011 Sep;35(5):790-819 PubMed
Braz J Microbiol. 2016 Oct - Dec;47(4):785-792 PubMed
J Clin Microbiol. 2011 Feb;49(2):539-48 PubMed
Antimicrob Agents Chemother. 2009 Sep;53(9):3628-34 PubMed
Antimicrob Agents Chemother. 2016 Jun 20;60(7):3921-33 PubMed
Infect Control Hosp Epidemiol. 2009 Mar;30(3):257-63 PubMed
Jundishapur J Microbiol. 2015 Jul 27;8(7):e17167 PubMed
J Clin Microbiol. 2005 Sep;43(9):4382-90 PubMed
FEMS Microbiol Lett. 1993 Aug 1;111(2-3):189-95 PubMed
Antimicrob Agents Chemother. 2011 Jul;55(7):3201-6 PubMed
Osong Public Health Res Perspect. 2015 Apr;6(2):79-86 PubMed
J Clin Microbiol. 2010 Dec;48(12):4592-4 PubMed
Am J Infect Control. 2010 Jun;38(5 Suppl 1):S25-33 PubMed
Drugs. 2014 Aug;74(12):1315-33 PubMed
Microb Drug Resist. 2013 Oct;19(5):397-406 PubMed
J Antimicrob Chemother. 2010 Jun;65(6):1162-70 PubMed
Int J Antimicrob Agents. 2011 Jun;37(6):525-30 PubMed
Lancet Infect Dis. 2016 Feb;16(2):161-8 PubMed
J Infect Dis. 2013 Oct 1;208(7):1142-51 PubMed
Clin Infect Dis. 2015 May 1;60(9):1295-303 PubMed
J Antimicrob Chemother. 2012 Jul;67(7):1607-15 PubMed
Clin Microbiol Infect. 2012 Mar;18(3):268-81 PubMed
Antimicrob Agents Chemother. 2011 Jul;55(7):3370-9 PubMed
Clin Microbiol Infect. 2007 Aug;13(8):807-15 PubMed
J Infect Chemother. 2009 Dec;15(6):361-6 PubMed
Antimicrob Agents Chemother. 2007 Oct;51(10):3471-84 PubMed
Antimicrob Agents Chemother. 2010 Dec;54(12):4971-7 PubMed